Form 4: Regeneron Pharmaceuticals Executive Joseph LaRosa Reports Stock Gift
SEC Form 4
Joseph LaRosa, EVP General Counsel and Secretary of Regeneron Pharmaceuticals, reported a gift of 1,608 shares of common stock.
Summary
- On June 10, 2024, Joseph LaRosa, EVP General Counsel and Secretary of Regeneron Pharmaceuticals, reported a transaction involving the company's common stock.
- The transaction involved a gift of 1,608 shares of common stock.
- Following the transaction, LaRosa directly owns 36,437 shares and indirectly owns 371 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to the market.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of transaction (gift of common stock) |
| 06/12/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.